AngioDynamics has teamed up with the University College London Hospital (UCLH) in the UK to launch a prospective registry ...

There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...

Over the past few days at the 128th Annual Meeting of the American Academy of Ophthalmology (AAO) 2024 in Chicago, US, the ...

The study will evaluate the company’s Gen-3 Halo headset as an at-home treatment for mild traumatic brain injury.

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Otsuka has reported positive interim results from its Phase III trial evaluating sibeprenlimab, a treatment for adults with ...

The trial aims to enrol NSCLC patients who have not responded to frontline platinum-based and immune checkpoint inhibitor therapies. Credit: New Africa/Shutterstock. Genelux has dosed the first ...

Conducted across 34 sites in the US, the trial enrolled 301 adults with MDD. Credit: Suriyawut Suriya/Shutterstock. Alto Neuroscience (Alto) has reported that its Phase IIb clinical trial of ALTO-100 ...

During IDWeek 2024 in the US, novel antimicrobials in the development pipeline that are poised to make a difference were ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Galderma has reported positive data from a Phase III clinical trial of RelabotulinumtoxinA for treating frown lines and ...